ID

39199

Description

A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers; ODM derived from: https://clinicaltrials.gov/show/NCT00938262

Lien

https://clinicaltrials.gov/show/NCT00938262

Mots-clés

  1. 09/12/2019 09/12/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

9 décembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Essential Hypertension NCT00938262

Eligibility Essential Hypertension NCT00938262

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age: 20 - 45 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
sex: male
Description

Gender

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
body weight: greater than 55 kg
Description

Body Weight

Type de données

boolean

Alias
UMLS CUI [1]
C0005910
written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known allergy to fimasartan, ketoconazole and rifampicin
Description

Hypersensitivity Fimasartan | Ketoconazole allergy | Rifampicin allergy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2825622
UMLS CUI [2]
C0571275
UMLS CUI [3]
C0571521
existing cardiac or hematological diseases
Description

Heart Disease | Hematological Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0018939
existing hepatic and renal diseases
Description

Liver diseases | Kidney Diseases

Type de données

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0022658
existing gastrointestinal diseases
Description

Gastrointestinal Diseases

Type de données

boolean

Alias
UMLS CUI [1]
C0017178
acute or chronic diseases which could affect drug absorption or metabolism
Description

Disease Affecting Drug absorption | Disease Affecting Drug metabolism | Chronic disease Affecting Drug absorption | Chronic disease Affecting Drug metabolism

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0678745
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0683140
UMLS CUI [3,1]
C0008679
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C0678745
UMLS CUI [4,1]
C0008679
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C0683140
history of any serious psychological disorder
Description

Serious mental illness

Type de données

boolean

Alias
UMLS CUI [1]
C3841614
positive drug or alcohol screening
Description

Drug screen positive | Alcohol consumption screening Positive

Type de données

boolean

Alias
UMLS CUI [1]
C0743295
UMLS CUI [2,1]
C0420032
UMLS CUI [2,2]
C1514241
smokers of 10 or more cigarettes per day 3 month ago
Description

Tobacco use Number of cigarettes per day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0543414
UMLS CUI [1,2]
C3694146
participation in a clinical trial during the last 2 months prior to the start of the study
Description

Study Subject Participation Status | Clinical Trial

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976

Similar models

Eligibility Essential Hypertension NCT00938262

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age: 20 - 45 years
boolean
C0001779 (UMLS CUI [1])
Gender
Item
sex: male
boolean
C0079399 (UMLS CUI [1])
Body Weight
Item
body weight: greater than 55 kg
boolean
C0005910 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Fimasartan | Ketoconazole allergy | Rifampicin allergy
Item
known allergy to fimasartan, ketoconazole and rifampicin
boolean
C0020517 (UMLS CUI [1,1])
C2825622 (UMLS CUI [1,2])
C0571275 (UMLS CUI [2])
C0571521 (UMLS CUI [3])
Heart Disease | Hematological Disease
Item
existing cardiac or hematological diseases
boolean
C0018799 (UMLS CUI [1])
C0018939 (UMLS CUI [2])
Liver diseases | Kidney Diseases
Item
existing hepatic and renal diseases
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
Gastrointestinal Diseases
Item
existing gastrointestinal diseases
boolean
C0017178 (UMLS CUI [1])
Disease Affecting Drug absorption | Disease Affecting Drug metabolism | Chronic disease Affecting Drug absorption | Chronic disease Affecting Drug metabolism
Item
acute or chronic diseases which could affect drug absorption or metabolism
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0683140 (UMLS CUI [2,3])
C0008679 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0678745 (UMLS CUI [3,3])
C0008679 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0683140 (UMLS CUI [4,3])
Serious mental illness
Item
history of any serious psychological disorder
boolean
C3841614 (UMLS CUI [1])
Drug screen positive | Alcohol consumption screening Positive
Item
positive drug or alcohol screening
boolean
C0743295 (UMLS CUI [1])
C0420032 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
Tobacco use Number of cigarettes per day
Item
smokers of 10 or more cigarettes per day 3 month ago
boolean
C0543414 (UMLS CUI [1,1])
C3694146 (UMLS CUI [1,2])
Study Subject Participation Status | Clinical Trial
Item
participation in a clinical trial during the last 2 months prior to the start of the study
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial